Health committee  I think one of the skills in developing a national brain strategy will be to pay close attention to the balance between funding the clinical trials of treatments once it is in effect too late—the horse is getting out the door—versus doing etiological studies that may lead to prev

Health committee  I think as you work backwards from the very end stages of all of these diseases, there are so many similarities, more commonalities as people approach the end of their condition. As has been already said, as you move upstream the disabling effects are broadly similar, so we have

Health committee  It seems to make a whole lot of sense to me. When I was working on Alzheimer's disease, we did an intensive study on the costs to caregivers and collected national data on that. We were able to model it. One of the advantages of the study that Dr. Bray described is that not only